Profil
Ludovic Helfgott is currently Council President at Novo Nordisk Haemophilia Foundation.
Formerly, Mr. Helfgott was Global Vice President at AstraZeneca PLC and Executive Vice President & Head-Rare Disease at Novo Nordisk A from 2019 to 2025.
Education includes an MBA from INSEAD (2001), and graduate degrees from Sciences Po (1994) and ESSEC Business School (1996).
Postes actifs de Ludovic Helfgott
| Sociétés | Poste | Début |
|---|---|---|
Novo Nordisk Haemophilia Foundation | Corporate Officer/Principal | - |
Anciens postes connus de Ludovic Helfgott
| Sociétés | Poste | Fin |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Formation de Ludovic Helfgott
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sciences Po
Sciences Po Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ESSEC Business School
ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo Nordisk Haemophilia Foundation |
















